Electronic cigarettes first emerged in the U.S. market around 2007, marketed as a safer alternative to traditional tobacco. By the mid-2010s, a youth vaping epidemic had exploded, driven largely by flavored products with appealing names and sleek designs. In response, federal regulators spent nearly a decade constructing guardrails — a premarket authorization system requiring companies to prove their products posed no public health threat before reaching store shelves.
Those guardrails are now being dismantled.
In the span of just two weeks, the Trump administration granted marketing authorization to four flavored vaping products and issued new FDA guidance allowing unauthorized vapes to remain on the market — products that are, by current law, illegal to sell without official approval. The guidance reframes the agency’s massive application backlog not as a crisis to solve, but as a reason to step aside.
Critics say the timing is no coincidence. The tobacco industry poured over $10 million into Trump’s 2024 reelection campaign, with RAI Services Co. — a subsidiary of Reynolds American — serving as the largest corporate donor. Toward the end of the campaign, Trump explicitly vowed to “save vaping.”
The consequences for public health could be severe. Brian King, former director of the FDA’s Center for Tobacco Products, warned: “We’ve reached a period of regulatory reckoning. It’s evident that there’s now greater responsiveness to authorizing more tobacco products for sale on particularly flavored products, and also less ability to resist political interference.” He added: “Political interference is the death knell of evidence-based regulation.”
Former CTP Director Mitch Zeller was equally alarmed, calling the new guidance “a get out of jail free card for illegal products that remain in the market until FDA finishes its scientific review. It’s a huge gift to the industry and it’s inconsistent with the law.”
Youth vaping rates had been declining — dropping from 2.13 million middle and high school students in 2023 to 1.63 million in 2024, according to FDA data. Health advocates fear that trend is now at risk.
The timing of this guidance raises serious concerns about priorities and commitment to protecting kids,” said Ranjana Caple, director of federal advocacy for the American Lung Association. “The agency seems to be waving the white flag rather than restoring order to the marketplace.”
The rollback also cost the administration one of its own. HHS Secretary RFK Jr.’s chief spokesperson, Rich Danker, cited vaping policy directly in his resignation letter, writing that “senior HHS officials…have in recent months sought U.S. Food and Drug Administration marketing approval of cigarette flavors that would appeal to children and expose them to nicotine addiction, lung damage and higher risk of cancer.”
What was built over nearly a decade to protect young Americans from nicotine addiction is being undone in weeks — a stark reminder of how quickly political influence can override public health evidence.
